米国の創傷治療市場の評価：製品別、用途別、購入形態別、流通チャネル別、エンドユーザー別、地域別、機会、予測、2017年～2031年

米国の創傷治療の市場規模は、2023年に52億1,000万米ドルとなりました。同市場は、2031年には90億2,000万米ドルに達すると予測され、2024年～2031年の予測期間のCAGRは7.1%になるとみられています。高齢化人口の増加、外科手術件数の増加、慢性創傷、潰瘍、糖尿病性潰瘍の有病率の増加、さまざまな創傷を治療するための先進的な製品を発売する主要企業の焦点のシフトが、米国市場を牽引しています。

近年、市場は革新的な創傷被覆材、生物製剤、再生医療アプローチなど、創傷治療技術の著しい進歩を遂げており、これらはすべて治癒プロセスと患者の転帰を改善することを目的としています。この市場の特徴は、従来の創傷被覆材、陰圧創傷治療、高気圧酸素療法、生物活性創傷被覆材や代用皮膚などの先進創傷治療製品など、多様な製品とサービスです。在宅医療や外来創傷治療クリニックが脚光を浴びるようになり、患者は従来の病院以外の場所でも質の高い創傷治療を受けられるようになっています。その結果、米国の創傷治療市場はますます患者中心のものとなり、慢性的な創傷や怪我を抱える患者の生活の質を全体的に向上させることに重点を置くようになっています。製薬会社から医療機器メーカーに至るまで、市場関係者はこのような需要の高まりに対応し、米国での創傷治療の成果をさらに高めるために研究開発に投資しています。

当レポートでは、米国の創傷治療市場について調査し、市場の概要とともに、製品別、用途別、購入形態別、流通チャネル別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 調査手法

第2章 プロジェクトの範囲と定義

第3章 COVID-19が米国の創傷治療市場に与える影響

第4章 エグゼクティブサマリー

第5章 米国の創傷治療市場の見通し、2017年～2031年

• 市場規模と予測
• 製品別
• 用途別
• 購入形態別
• 流通チャネル別
• エンドユーザー別
• 地域別
• 企業別市場シェア（％）、2023年

第6章 市場マッピング、2023年

第7章 マクロ環境と産業構造

• 供給需要分析
• 輸出入分析- 数量と価値
• サプライ/バリューチェーン分析
• PESTEL分析
• ポーターのファイブフォース分析

第8章 市場力学

第9章 規制枠組みとイノベーション

第10章 主要参入企業の情勢

第11章 価格分析

第12章 ケーススタディ

第13章 主要参入企業の見通し

• Johnson and Johnson
• 3M Co
• Smith & Nephew
• ConvaTec Group PLC
• Cardinal Health
• Medtronic
• Integra Lifesciences
• Medline Industries, LP

第14章 戦略的提言

第15章 お問い合わせと免責事項

List of Tables

• Table 1. Pricing Analysis of Products from Key Players
• Table 2. Competition Matrix of Top 5 Market Leaders
• Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
• Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

• Figure 1. United States Wound Care Market, By Value, in USD Billion, 2017-2031F
• Figure 2. United States Wound Care Market, By Volume, in Million Units, 2017-2031F
• Figure 3. United States Wound Care Market Share (%), By Product, 2017-2031F
• Figure 4. United States Wound Care Market Share (%), By Applications, 2017-2031F
• Figure 5. United States Wound Care Market Share (%), By Mode of Purchase, 2017-2031F
• Figure 6. United States Wound Care Market Share (%), Distribution Channel, 2017-2031F
• Figure 7. United States Wound Care Market Share (%), By End-user, 2017-2031F
• Figure 8. United States Wound Care Market Share (%), By Region, 2017-2031F
• Figure 9. By Product Map-Market Size (USD Billion) & Growth Rate (%), 2023
• Figure 10. By Applications Map-Market Size (USD Billion) & Growth Rate (%), 2023
• Figure 11. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
• Figure 12. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023

United States wound care market size was valued at USD 5.21 billion in 2023, and is expected to reach USD 9.02 billion in 2031, with a CAGR of 7.1% for the forecast period between 2024 and 2031F. The growing aging population, increasing number of surgical procedures, increasing prevalence of chronic wounds, ulcers, and diabetic ulcers, and the shift in focus of key players to launch advanced products to treat various wounds are driving the market in the United States.

In recent years, the market has witnessed significant advancements in wound care technologies, including innovative wound dressings, biologics, and regenerative medicine approaches, all aimed at improving the healing process and patient outcomes. The market is characterized by a diverse range of products and services, including traditional wound dressings, negative pressure wound therapy, hyperbaric oxygen therapy, and advanced wound care products such as bioactive wound dressings and skin substitutes. Home healthcare and outpatient wound care clinics have gained prominence, enabling patients to receive high-quality wound care outside traditional hospital settings. As a result, the United States wound care market has become increasingly patient-centric, focusing on improving the overall quality of life for individuals dealing with chronic wounds and injuries. Market players, ranging from pharmaceutical companies to medical device manufacturers, are investing in research and development to meet this growing demand and further enhance wound care outcomes in the United States

Increasing Number of Hospitals with Advanced Resources

The growing presence of established hospitals featuring specialized wound management centers stands out as a pivotal driver for market expansion. Furthermore, the increase in the admission of patients with chronic wounds can be attributed to the presence of advanced medical equipment and the comprehensive reimbursement policies extended by hospitals, further fueling the growth of the United States wound care market. Additionally, hospitals are forging partnerships with key industry players to increase awareness and deliver acute wound management services, thereby fostering market advancement. In April 2022, Healogics collaborated with Vizient Hospital to efficiently deliver outpatient wound management and treatment services. In December 2021, Smith & Nephew obtained FDA approval for its PICO 7 Single Use Negative Pressure Wound Therapy System, designed for the removal of exudates from a range of wound types. The system is compatible for use in both hospital and homecare settings.

Growing Incidence of Acute and Chronic Wounds

The increasing incidence of both acute and chronic wounds stands as a significant factor shaping the market's growth in the years to come. As per a 2021 article published in NCBI, chronic wounds such as diabetic foot ulcers, pressure ulcers, leg ulcers, and others are mostly found in individuals aged 65 years and older, with an expected impact on around 2% of the entire population of the United States. According to a 2022 report released by the Centers for Disease Control and Prevention, approximately 37.3 million individuals in the United States were living with diabetes. Furthermore, numerous research articles have reported that approximately 2-5% of the United States population with diabetes mellitus develop diabetic foot ulcers. As reported by the Agency for Healthcare Research and Quality, approximately 2.5 million individuals in the United States experience pressure ulcers each year. Additionally, these ulcers are notably common among the elderly population. Moreover, according to data from the United Health Foundation, there are approximately 54 million adults aged 65 years and older residing in the country, and this figure is anticipated to grow to 85.7 million by 2050. Consequently, the increasing population of elderly individuals is expected to increase the likelihood of pressure ulcers among this group, consequently driving the demand for chronic wound treatment products in the future.

Introduction of Technologically Advanced Products

The market is expected to witness a surge in product adoption among patients, primarily due to the changing priorities of prominent companies like ConvaTec Group Plc and Smith & Nephew, who are placing greater emphasis on research and development, along with the introduction of innovative products in the country. Furthermore, the growing support from regulatory agencies for a wide range of wound management products is projected to further bolster the market's expansion. In January 2023, ConvaTec Group PLC introduced ConvaFoam in the United States. The ConvaFoam dressing line incorporates advanced silicone technology to enhance adhesion, extends wear time to seven days, improves absorbency, includes superabsorbent layers, and enables continuous monitoring. These innovations make the product suitable for a wide range of wound types.

Partnerships Between Leading Market Players

Leading companies in the United States actively engage in strategic acquisitions to bolster their presence and expand their product portfolios. These acquisitions reflect the industry's ongoing commitment to innovation and the delivery of advanced wound care products and services, enhancing their capacity to meet the growing healthcare needs of patients across the United States. In November 2022, InfuSystem Holdings, Inc. entered a collaboration with Sanara MedTech Inc., resulting into the establishment of SI Wound Care, LLC. The partnership primarily aims to create a comprehensive wound management solution aimed at enhancing patient outcomes while effectively reducing costs. In November 2021, Convatec Group PLC renewed its contract partnership with Vizient, Inc. for an additional three years, with the overarching goal of providing top-tier products to assist patients and caregivers in their wound care needs.

Impact of COVID-19

The pandemic's emergence resulted in a decline in the market. Wound management was excluded from the list of essential procedures during the pandemic, leading to adverse effects on the market. In the initial stages of the pandemic, the healthcare workforce primarily directed their efforts towards crisis management. Additionally, widespread lockdown measures aimed at mitigating virus spread led to the closure of non-essential clinics and postponed patient visits, significantly affecting the market. According to a 2021 research article published by HMP Global, over 40% of wound treatment clinics experienced temporary closures in 2020. Additionally, hospital-based outpatient departments saw a significant decrease of 60% in patient visits during that time. Several industry participants in the nation reported a substantial decrease in their earnings throughout the pandemic. For example, Smith & Nephew, saw a 5.1% drop in revenue from its advanced wound care business segment in 2020 as compared to 2019. This decline was attributed to a reduction in elective surgeries and restrictions placed on healthcare facility access.

Key Players Landscape and Outlook

The United States wound care market exhibits a semi-consolidated structure, with a selected group of established players operating in the advanced wound products sector, while others focus on traditional products. Prominent companies like 3M, Smith & Nephew, and Convatec Group PLC, among others, command a substantial share in the United States wound care market. The growth of these companies is driven by a surge in strategic initiatives, including the introduction of new products, the expansion of sales channels, and the adoption of inorganic strategies to fortify their market presence within the country. In January 2023, ConvaTec Group PLC introduced ConvaFoam in the United States. The ConvaFoam dressing line incorporates advanced silicone technology to enhance adhesion, extends wear time to seven days, improves absorbency, include superabsorbent layers, and enable exudate monitoring.

Table of Contents

1. Research Methodology

2. Project Scope & Definitions

3. Impact of COVID-19 on United States Wound Care Market

4. Executive Summary

5. United States Wound Care Market Outlook, 2017-2031F

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
  • 5.1.2. By Volume
• 5.2. By Product
  • 5.2.1. Advanced Wound Dressings
    • 5.2.1.1. Foam Dressings
    • 5.2.1.2. Hydrocolloid Dressings
    • 5.2.1.3. Film Dressings
    • 5.2.1.4. Alginate Dressings
    • 5.2.1.5. Hydrogel Dressings
    • 5.2.1.6. Collagen Dressings
    • 5.2.1.7. Others
  • 5.2.2. Surgical Wound Care
    • 5.2.2.1. Sutures & Staples
    • 5.2.2.2. Tissue Adhesive and Sealants
    • 5.2.2.3. Anti-Infective Dressing
  • 5.2.3. Traditional Wound Care
    • 5.2.3.1. Medical Tapes
    • 5.2.3.2. Cotton
    • 5.2.3.3. Bandages
    • 5.2.3.4. Gauzes
    • 5.2.3.5. Sponges
    • 5.2.3.6. Cleansing Agents
  • 5.2.4. Wound Therapy Devices
    • 5.2.4.1. Negative Pressure Wound Therapy
    • 5.2.4.2. Oxygen And Hyperbaric Oxygen Equipment
    • 5.2.4.3. Electric Stimulation Devices
    • 5.2.4.4. Pressure Relief Devices
    • 5.2.4.5. Others
• 5.3. By Applications
  • 5.3.1. Chronic Wounds
    • 5.3.1.1. Diabetic Foot Ulcers
    • 5.3.1.2. Pressure Ulcers
    • 5.3.1.3. Venous Leg Ulcers
    • 5.3.1.4. Other
  • 5.3.2. Acute Wounds
    • 5.3.2.1. Surgical & Traumatic Wounds
    • 5.3.2.2. Burns
• 5.4. By Mode of Purchase
  • 5.4.1. Prescribed
  • 5.4.2. Non-Prescribed
• 5.5. By Distribution Channel
  • 5.5.1. Institutional Sales
  • 5.5.2. Retail Sales
• 5.6. By End-user
  • 5.6.1. Hospitals
  • 5.6.2. Outpatient Facilities
  • 5.6.3. Home Care
  • 5.6.4. Research & Manufacturing
• 5.7. By Region
  • 5.7.1. Northeast
  • 5.7.2. Southwest
  • 5.7.3. West
  • 5.7.4. Midwest
  • 5.7.5. Southeast
• 5.8. By Company Market Share (%), 2023

6. Market Mapping, 2023

• 6.1. By Product
• 6.2. By Application
• 6.3. By End-User
• 6.4. By Mode of Purchase
• 6.5. Distribution Channel
• 6.6. By Region

7. Macro Environment and Industry Structure

• 7.1. Supply Demand Analysis
• 7.2. Import Export Analysis - Volume and Value
• 7.3. Supply/Value Chain Analysis
• 7.4. PESTEL Analysis
  • 7.4.1. Political Factors
  • 7.4.2. Economic System
  • 7.4.3. Social Implications
  • 7.4.4. Technological Advancements
  • 7.4.5. Environmental Impacts
  • 7.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
• 7.5. Porter's Five Forces Analysis
  • 7.5.1. Supplier Power
  • 7.5.2. Buyer Power
  • 7.5.3. Substitution Threat
  • 7.5.4. Threat from New Entrant
  • 7.5.5. Competitive Rivalry

8. Market Dynamics

• 8.1. Growth Drivers
• 8.2. Growth Inhibitors (Challenges, Restraints)

9. Regulatory Framework and Innovation

• 9.1. Patent Landscape
• 9.2. Regulatory Approvals
• 9.3. Innovations/Emerging Technologies

10. Key Players Landscape

• 10.1. Competition Matrix of Top Five Market Leaders
• 10.2. Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
• 10.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
• 10.4. SWOT Analysis (For Five Market Players)
• 10.5. Patent Analysis (If Applicable)

11. Pricing Analysis

12. Case Studies

13. Key Players Outlook

• 13.1. Johnson and Johnson
  • 13.1.1. Company Details
  • 13.1.2. Key Management Personnel
  • 13.1.3. Products & Services
  • 13.1.4. Financials (As reported)
  • 13.1.5. Key Market Focus & Geographical Presence
  • 13.1.6. Recent Developments
• 13.2. 3M Co
• 13.3. Smith & Nephew
• 13.4. ConvaTec Group PLC
• 13.5. Cardinal Health
• 13.6. Medtronic
• 13.7. Integra Lifesciences
• 13.8. Medline Industries, LP

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

14. Strategic Recommendations

15. About Us & Disclaimer